Latest International Markets News

ClearVue Technologies has raised A$4.6 million in a strongly supported placement to accelerate international certification and ongoing innovation of its solar façade products.

PainChek Limited has achieved a landmark FDA De Novo classification for its PainChek Adult App, positioning it as the first regulated medical device for pain assessment in the US aged care sector and opening a $100 million annual market opportunity.

ECS Botanics reports a positive cash flow milestone in Q1 FY26, driven by strong direct-to-consumer sales and operational efficiencies, while preparing for a European market debut.

Artrya Limited has successfully completed a strongly supported Share Purchase Plan, raising approximately A$5 million despite significant oversubscription. This follows a recent $75 million placement, underscoring investor confidence in its AI-driven coronary artery disease platform.

The Calmer Co International Limited has reported its strongest quarterly revenue ever at $2.4 million, driven by robust Australian retail sales and expanding US market presence. The company is also advancing a $1.4 million convertible note to fuel growth and inventory expansion.

Orthocell has reported a record $3 million revenue for the September quarter, driven by strong sales of its nerve repair product Remplir™ in Australia and Singapore, with early US sales and Canadian market entry poised to accelerate growth.

Broken Hill Mines has locked in a US$25 million senior secured financing facility alongside a major silver-lead concentrate offtake agreement with Hartree Metals, underpinning growth at its Rasp and Pinnacles mines.

Gowing Bros. Limited posted a $3.29 million loss for FY25 but declared a fully franked 3 cent final dividend, highlighting ongoing development at Sawtell Commons and a strong sustainability agenda.

Firebird Metals has raised A$6 million through a placement led by top-tier institutions and directors, aiming to fast-track its manganese-rich cathode technology and expand R&D capabilities in Australia and China.

The Calmer Co. has secured $700,000 in the first tranche of a $1.4 million convertible note raise, welcoming US distributor Applied Food Sciences as a strategic investor to fuel its expanding wholesale presence.

Murray Cod Australia has raised approximately A$17 million through an institutional placement to fund a significant expansion in production capacity and sales capabilities as it enters a pivotal growth phase.

KMD Brands reported a modest 1% sales increase in FY25 but faced a sharp 65% drop in underlying EBITDA, prompting a bold 'Next Level' turnaround strategy targeting margin expansion and debt reduction in FY26.